Ömer Dızdar

2.9k total citations
141 papers, 1.5k citations indexed

About

Ömer Dızdar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Ömer Dızdar has authored 141 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Oncology, 38 papers in Pulmonary and Respiratory Medicine and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Ömer Dızdar's work include Cancer Immunotherapy and Biomarkers (18 papers), Breast Cancer Treatment Studies (13 papers) and HER2/EGFR in Cancer Research (12 papers). Ömer Dızdar is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), Breast Cancer Treatment Studies (13 papers) and HER2/EGFR in Cancer Research (12 papers). Ömer Dızdar collaborates with scholars based in Türkiye, United States and India. Ömer Dızdar's co-authors include Kadri Altundağ, Sercan Aksoy, Hakan Harputluoğlu, Saadettin Kılıçkap, Çağatay Arslan, Deniz Can Güven, Mutlu Hayran, İbrahim Barışta, Didem Şener Dede and Şuayib Yalçın and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Spine.

In The Last Decade

Ömer Dızdar

124 papers receiving 1.4k citations

Peers

Ömer Dızdar
Comparison fields: 5 of 106
  • Oncology 748
  • Pulmonary and Respiratory Medicine 307
  • Molecular Biology 242
  • Cancer Research 181
  • Epidemiology 178
Replace Ulla M. Saarinen‐Pihkala with:
Ulla M. Saarinen‐Pihkala Finland
Rasim Gucalp United States
Atul Sharma India
Hooman Yarmohammadi United States
L.M. Jost Switzerland
Florian Moik Austria
Jason Tay Canada
Dirk Schrijvers Belgium
Marwan Ghosn Lebanon
Maureen Reiner United States
Ulla M. Saarinen‐Pihkala Finland View profile →
Citations per field, relative to Ömer Dızdar
Ömer Dızdar · 1×
Citations per year, relative to Ömer Dızdar
Ömer Dızdar · 1×

Countries citing papers authored by Ömer Dızdar

Since Specialization
Citations

This map shows the geographic impact of Ömer Dızdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömer Dızdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömer Dızdar more than expected).

Fields of papers citing papers by Ömer Dızdar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ömer Dızdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömer Dızdar. The network helps show where Ömer Dızdar may publish in the future.

Co-authorship network of co-authors of Ömer Dızdar

This figure shows the co-authorship network connecting the top 25 collaborators of Ömer Dızdar. A scholar is included among the top collaborators of Ömer Dızdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ömer Dızdar. Ömer Dızdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 2
3 1
4 1
5 7
6 1
7 11
8 4
9 5
10 2
11 10
12 2
13 3
14 3
15 0
16 26
17 16
18 1
19 24
20
Gastrointestinal stromal tümörler ve imatinib (Glivec®) tedavisi
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026